Early Diagnosis of Oral Cancer: A Review
Oral cancer (OC) is a global burden. India has become the epicentre of OC globally. As clinicians we are responsible for recognizing and detecting early or incipient changes of the oral mucosa, because, inspite of numerous advances in the treatment of OC, 5-year survival rate remains only 50%. This poor prognosis is due to several factors. However, single most effective route to improving the long-term outcome of OC is early diagnosis. Dentists must be keenly aware of oral mucosal alterations; any observed suspicious mucosal abnormality must be sampled using biopsy. A variety of commercial diagnostic aids and adjunctive techniques are available to potentially assist in the screening of healthy patients, for evidence of otherwise occult cancerous change or to assess the biologic potential of clinically abnormal mucosal lesions. This article is aimed at helping the clinicians, about the various aids or adjuncts that can be used in OC detection; a systematic review of the literature by way of descriptive design was used.
Chi T, Viet BS, Schmidt BL. Understanding oral cancer in the genome era. Head Neck (2010). 32(9): 1246–68.
Wang CY, Chiang HK, Chen CT, Chiang CP, Kuo YS, Chow SN. Diagnosis of oral cancer by light-induced autofluorescence spectroscopy using double excitation wavelengths. Oral Oncol (1999). 35(2): 144– 50.
Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol and tobacco use. J Can Res Ther (2010). 6(4): 487–92.
Truelove EL, Dean D, Maltby S, Griffith M, Huggins K, Griffith M, et al. Narrow band imaging of oral mucosain routine dental patients. Gen Dent (2011). 59(4): 281–89.
Gómez I, Warnakulasuriya S, Varela-Centelles PI, López-Jornet P, Suárez-Cunqueiro M, Diz-Dios P, et al. Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay? Oral Dis (2010). 16(4): 333–42.
Campo-trapero J, Cano-Sánchez J, Palacios-Sánchez B, Sánchez-Gutierrez JJ, González-Moles MA, Bascones-Martínez A. Update on molecular pathology in oral cancer and precancer. Anticancer Res (2008). 28(2B): 1197–206.
Rethnam MP, Carpenter W, Cohen Ezna EW, Epstein J, Evans. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas JADA (2010). 141: 509–20.
Joshi M, Patil R. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer. J Can Res Ther (2010). 6(3): 263–66.
Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: An adjunct for oral mucosal examinations. J Clin Dent (2006). 17(3): 59– 63.
Petruzzi M, Lucchese A, Baldoni E, Grassi FR, Serpico R. Use of Lugol’s iodine in oral cancer diagnosis: An overview. Oral Oncol (2010). 46(11): 811–13.
Sherin N, Simi T, Shameema PM, Sudha S. Changing trends in oral cancer.!! HYPERLINK “http:// www.ncbi.nlm.nih.gov/pubmed/19018111” o “Indian journal of cancer.” Indian J Cancer. (2008). 45(3): 93–96.
Papamarkakis K, Bird B, Schubert JM, Miljkoviæ M, Wein R, Bedrossian K. Cytopathology by optical methods: Spectral cytopathology of the oral mucosa. Lab Invest (2010). 90(4): 589–98.
Mehrotra R, Yadav S. Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic values of genomic alteration. Indian J Cancer (2006). 43: 60–66.
Rai S, Mody RN. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy. J Can Res Ther (2012). 8 Suppl 1: S116–22.
Mehrotra R. The role of cytology in Oral Lesions: A review of recent improvements. !! HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/21442772” o “Diagnostic cytopathology.” Diagn Cytopathol (2012). 40(1): 73–83.
Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specificity of the Oral CDx technique. Oral Oncol (2004). 40(8): 824–28.
Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. US Collaborative Oral CDx Study Group. J Am Dent Assoc (1999). 130(10): 1445– 1457.
Sciubba JJ. Oral cancer and its detection. JADA (2001). 132: 12s–18s.
Shah JP, Johnson NW, Batsakis JG. Oral cancer. United Kingdom: Martin Dunitz (2003).
Shetty SR, Chadha R, Babu S, Kumari S, Bhat S, Achalli S. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma. A biochemical and clinicopathological study. J Can Res and Ther (2012). 8 Suppl 1: S123–5.
Aswini YB. The genomics of oral cancer and wound healing. J Indian Soc Pedod Prevent Dent (2009). 27(1): 2–5.
Montserrat Sanchez-Cespedes, Steven A. Ahrendt, Steven Piantadosi, et al. Chromosomal Alterations in Lung Adenocarcinoma from Smokers and Nonsmokers 61(4): 1309–1313.